Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Voreloxin in Older Patients With Untreated Acute Myeloid Leukemia

This study has been completed.
Information provided by (Responsible Party):
Sunesis Pharmaceuticals Identifier:
First received: January 23, 2008
Last updated: June 5, 2012
Last verified: June 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2011
  Primary Completion Date: March 2010 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):